Table 1.
Genetic, Biochemical, and Clinical Findings in Individuals with Biallelic ATP5F1D Variants
| ID | Sex |
ATP5F1D Variants |
OXPHOS Activities in Cultured Skin Fibroblasts |
Clinical Presentation |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| cDNA (GenBank:NM_001687.4) | Protein (GenBank:NP_001687.1) | Respiratory Chain Complex | Mean Enzyme Activity (%) | Absolute Values | Normal Range of Activities | Muscle Biopsy | Age at Presentation | Salient Clinical Features | ||
| S1 | female | c.[245C>T];[245C>T] | p.[Pro82Leu];[Pro82Leu] | I | 83% | 24 | 18–53 | normal histology and respiratory chain enzymes | 2 days | hyperammonemia, cardiomyopathy, lactic acidosis, rhabdomyolysis fatigability, short stature |
| I + III | 267% | 310 | 61–220 | |||||||
| II | 92% | 71 | 54–124 | |||||||
| II + III | 130% | 180 | 79–219 | |||||||
| IV | 44% | 162 | 270–659 | |||||||
| V | 5% (↓↓↓) | 7 | 78–287 | |||||||
| CS | 63% | 197 | 225–459 | |||||||
| S2 | male | c.[317T>G];[317T>G] | p.[Val106Gly];[Val106Gly] | I | 93% | 27 | 18–53 | normal histology and respiratory chain enzymes | 4 years and 10 months | hyperammonemia, ketoacidosis, delayed speech |
| I + III | 151% | 174 | 61–220 | |||||||
| II | 98% | 76 | 54–124 | |||||||
| II + III | 139% | 193 | 79–219 | |||||||
| IV | 142% | 519 | 270–659 | |||||||
| V | 16% (↓↓) | 23 | 78–287 | |||||||
| CS | 101% | 314 | 225–459 | |||||||